BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005;242:566-573; discussion 573-575. [PMID: 16192817 DOI: 10.1097/01.sla.0000184211.75970.85] [Cited by in Crossref: 67] [Cited by in F6Publishing: 156] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Pech O, Ell C. Is vagal-sparing esophagectomy ideal for Barrett's esophagus with intramucosal adenocarcinoma or high-grade dysplasia? Nat Rev Gastroenterol Hepatol 2008;5:302-3. [DOI: 10.1038/ncpgasthep1127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149:302-17.e1. [PMID: 25957861 DOI: 10.1053/j.gastro.2015.04.053] [Cited by in Crossref: 182] [Cited by in F6Publishing: 175] [Article Influence: 26.0] [Reference Citation Analysis]
3 Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Braun S, Ell C, Lorenz D. Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma. World J Surg. 2020;44:1192-1199. [PMID: 31853591 DOI: 10.1007/s00268-019-05291-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Wang Y, Zhang X, Zhang X, Liu-Helmersson J, Zhang L, Xiao W, Jiang Y, Liu K, Sang S. Prognostic value of the extent of lymphadenectomy for esophageal cancer-specific survival among T1 patients. BMC Cancer 2021;21:403. [PMID: 33853577 DOI: 10.1186/s12885-021-08080-4] [Reference Citation Analysis]
5 Jayaprakasam VS, Yeh R, Ku GY, Petkovska I, Fuqua JL 3rd, Gollub M, Paroder V. Role of Imaging in Esophageal Cancer Management in 2020: Update for Radiologists. AJR Am J Roentgenol 2020;215:1072-84. [PMID: 32901568 DOI: 10.2214/AJR.20.22791] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pech O, May A, Rabenstein T, Ell C. Endoscopic resection of early oesophageal cancer. Gut. 2007;56:1625-1634. [PMID: 17938435 DOI: 10.1136/gut.2006.112110] [Cited by in Crossref: 89] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
7 Pech O, May A, Günter E, Gossner L, Ell C. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus. Am J Gastroenterol 2006;101:2223-9. [PMID: 17032186 DOI: 10.1111/j.1572-0241.2006.00718.x] [Cited by in Crossref: 96] [Cited by in F6Publishing: 73] [Article Influence: 6.0] [Reference Citation Analysis]
8 Lin Z, Chen W, Chen Y, Peng X, Yan S, He F, Fu R, Jiang Y, Hu Z. Achieving adequate lymph node dissection in treating esophageal squamous cell carcinomas by radical lymphadenectomy: Beyond the scope of numbers of harvested lymph nodes. Oncol Lett 2019;18:1617-30. [PMID: 31423229 DOI: 10.3892/ol.2019.10465] [Reference Citation Analysis]
9 Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, Räsänen J, Nafteux P, Pattyn P, Hölscher AH, Schröder W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, Bergman JJGHM, Hulshof MCCM, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SS. Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer 2019;19:662. [PMID: 31272485 DOI: 10.1186/s12885-019-5761-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 8.3] [Reference Citation Analysis]
10 Dermine S, Leconte M, Leblanc S, Dousset B, Terris B, Berger A, Berger A, Rahmi G, Lepilliez V, Plomteux O, Leclercq P, Coriat R, Chaussade S, Prat F, Barret M. Outcomes of esophagectomy after noncurative endoscopic resection of early esophageal cancer. Therap Adv Gastroenterol. 2019;12:1756284819892556. [PMID: 31839807 DOI: 10.1177/1756284819892556] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Künzli HT, Belghazi K, Pouw RE, Meijer SL, Seldenrijk CA, Weusten B, Bergman J. Endoscopic management and follow-up of patients with a submucosal esophageal adenocarcinoma. United European Gastroenterol J 2018;6:669-77. [PMID: 30083328 DOI: 10.1177/2050640617753808] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
12 Valmasoni M, Pierobon ES, Ruol A, De Pasqual CA, Zanchettin G, Moletta L, Salvador R, Costantini M, Merigliano S. Endoscopic Tumor Length Should Be Reincluded in the Esophageal Cancer Staging System: Analyses of 662 Consecutive Patients. PLoS One 2016;11:e0153068. [PMID: 27088503 DOI: 10.1371/journal.pone.0153068] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
13 Ngamruengphong S, Wolfsen HC, Wallace MB. Survival of patients with superficial esophageal adenocarcinoma after endoscopic treatment vs surgery. Clin Gastroenterol Hepatol. 2013;11:1424-1429.e2; quiz e81. [PMID: 23735443 DOI: 10.1016/j.cgh.2013.05.025] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 5.3] [Reference Citation Analysis]
14 Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma. Oncogene 2007;26:6456-68. [DOI: 10.1038/sj.onc.1210459] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 3.0] [Reference Citation Analysis]
15 Kauer WK, Siewert JR. Endoscopic mucosal resection. Gastric Cancer 2006;9:1-2. [PMID: 16557428 DOI: 10.1007/s10120-006-0359-6] [Reference Citation Analysis]
16 Wani S, Drahos J, Cook MB, Rastogi A, Bansal A, Yen R, Sharma P, Das A. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointest Endosc. 2014;79:224-232.e1. [PMID: 24060519 DOI: 10.1016/j.gie.2013.08.002] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 7.6] [Reference Citation Analysis]
17 Leggett CL, Gorospe EC, Wang KK. Endoscopic therapy for Barrett's esophagus and early esophageal adenocarcinoma. Gastroenterol Clin North Am 2013;42:175-85. [PMID: 23452637 DOI: 10.1016/j.gtc.2012.11.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
18 Manner H, Pech O, Heldmann Y, May A, Pauthner M, Lorenz D, Fisseler-Eckhoff A, Stolte M, Vieth M, Ell C. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2015;29:1888-1896. [PMID: 25294553 DOI: 10.1007/s00464-014-3881-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
19 Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong LM, Dunagan KT, Lutzke LS, Borkenhagen LS, Wang KK. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology. 2009;137:815-823. [PMID: 19524578 DOI: 10.1053/j.gastro.2009.05.059] [Cited by in Crossref: 235] [Cited by in F6Publishing: 190] [Article Influence: 18.1] [Reference Citation Analysis]
20 Law S, Wong J. The current management of esophageal cancer. Adv Surg 2007;41:93-119. [PMID: 17972559 DOI: 10.1016/j.yasu.2007.05.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
21 Lauwers GY, Badizadegan K. New Endoscopic Techniques: Challenges and Opportunities for Surgical Pathologists. Surg Pathol Clin 2010;3:411-28. [PMID: 26839138 DOI: 10.1016/j.path.2010.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Kahn A, Kamboj AK, Muppa P, Sawas T, Lutzke LS, Buras MR, Golafshar MA, Katzka DA, Iyer PG, Smyrk TC, Wang KK, Leggett CL. Staging of T1 esophageal adenocarcinoma with volumetric laser endomicroscopy: a feasibility study.Endosc Int Open. 2019;7:E462-E470. [PMID: 30931378 DOI: 10.1055/a-0838-5326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Wajed SA, Veeramootoo D, Shore AC. Video. Surgical optimisation of the gastric conduit for minimally invasive oesophagectomy. Surg Endosc. 2012;26:271-276. [PMID: 21858577 DOI: 10.1007/s00464-011-1855-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
24 Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol 2018; 24(41): 4698-4707 [PMID: 30416317 DOI: 10.3748/wjg.v24.i41.4698] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
25 Mukherjee K, Chakravarthy AB, Goff LW, El-Rifai W. Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy. Dig Dis Sci 2010;55:3304-14. [PMID: 20300841 DOI: 10.1007/s10620-010-1187-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
26 Macías-García F, Domínguez-Muñoz JE. Update on management of Barrett's esophagus. World J Gastrointest Pharmacol Ther 2016; 7(2): 227-234 [PMID: 27158538 DOI: 10.4292/wjgpt.v7.i2.227] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Konda VJ, Ferguson MK. Esophageal resection for high-grade dysplasia and intramucosal carcinoma: When and how? World J Gastroenterol 2010; 16(30): 3786-3792 [PMID: 20698041 DOI: 10.3748/wjg.v16.i30.3786] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
28 Stein HJ, Schweigert M, Dubecz A. [Early esophageal cancer: pro surgical resection]. Chirurg 2011;82:495-9. [PMID: 21598061 DOI: 10.1007/s00104-010-2038-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Mitchell DP, Yeluri S, Van der Wall H, Falk GL. The real risk of nodal disease in T1 oesophageal adenocarcinoma: A systematic review. Eur Surg 2020;52:110-7. [DOI: 10.1007/s10353-019-00627-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Dutta S, Going JJ, Crumley AB, Mohammed Z, Orange C, Edwards J, Fullarton GM, Horgan PG, McMillan DC. The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma. Br J Cancer 2012;106:702-10. [PMID: 22240784 DOI: 10.1038/bjc.2011.610] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
31 Demeester SR. New Options for the Therapy of Barrett’s High-Grade Dysplasia and Intramucosal Adenocarcinoma: Endoscopic Mucosal Resection and Ablation versus Vagal-Sparing Esophagectomy. The Annals of Thoracic Surgery 2008;85:S747-50. [DOI: 10.1016/j.athoracsur.2007.10.102] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
32 Veeramootoo D, Shore AC, Shields B, Krishnadas R, Cooper M, Berrisford RG, Wajed SA. Ischemic conditioning shows a time-dependant influence on the fate of the gastric conduit after minimally invasive esophagectomy. Surg Endosc 2010;24:1126-31. [PMID: 19997936 DOI: 10.1007/s00464-009-0739-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
33 Qin J, Peng Y, Chen W, Ma H, Zheng Y, Li Y, Wang J. Comparative study of esophagectomy, endoscopic therapy, and radiotherapy for cT1N0M0 esophageal cancer in elderly patients: A SEER database analysis. Thorac Cancer 2019;10:1511-20. [PMID: 31199600 DOI: 10.1111/1759-7714.13080] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
34 Leggett CL, Prasad GA. High-grade dysplasia and intramucosal adenocarcinoma in Barrett’s esophagus: the role of endoscopic eradication therapy. Curr Opin Gastroenterol. 2012;28:354-361. [PMID: 22450896 DOI: 10.1097/mog.0b013e328352b78a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Lim SM, Jung ES, Shin SK, Chung HS, Kim HI, Kim do W, Cho BC. A case of synchronous squamous cell carcinoma in the esophagus and stomach. Gut Liver. 2012;6:118-121. [PMID: 22375181 DOI: 10.5009/gnl.2012.6.1.118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
36 Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Coit DG, Brennan MF. Lymphadenectomy for Adenocarcinoma of the Gastroesophageal Junction (GEJ): Impact of Adequate Staging on Outcome. Ann Surg Oncol 2007;14:306-16. [DOI: 10.1245/s10434-006-9166-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 3.4] [Reference Citation Analysis]
37 Rajendra S, Sharma P. Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol. 2012;5:285-299. [PMID: 22973415 DOI: 10.1177/1756283x12446668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
38 Zhang R, Han D, Li L, Luo W, Liu J, Qian L. EphA5 Silencing Increases the Radiosensitivity of ESCC Cells Through ATM-Dependent Pathway. Cancer Manag Res 2020;12:9539-49. [PMID: 33061640 DOI: 10.2147/CMAR.S261182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Guan H, Yu Y, Ge H, Zhu S, Huang W, Li B. Implication of clinical target delineation for T1b/T2 thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases. Future Oncol 2019;15:3345-55. [PMID: 31578872 DOI: 10.2217/fon-2019-0266] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
40 Wang Z, Li H, Li F, Su X, Zhang J. Bioinformatics-Based Identification of a circRNA-miRNA-mRNA Axis in Esophageal Squamous Cell Carcinomas. J Oncol 2020;2020:8813800. [PMID: 33061972 DOI: 10.1155/2020/8813800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Fotis D, Doukas M, Wijnhoven BP, Didden P, Biermann K, Bruno MJ, Koch AD. Submucosal invasion and risk of lymph node invasion in early Barrett's cancer: potential impact of different classification systems on patient management. United European Gastroenterol J 2015;3:505-13. [PMID: 26668743 DOI: 10.1177/2050640615581965] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
42 Song G, Jing W, Xue S, Guo H, Yu J. The prognostic value of nodal skip metastasis in resectable thoracic esophageal squamous cell carcinoma. Onco Targets Ther 2017;10:2729-36. [PMID: 28579811 DOI: 10.2147/OTT.S132062] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Bogoevski D, Bockhorn M, Koenig A, Reeh M, von Loga K, Sauter G, Rösch T, Izbicki JR. How radical should surgery be for early esophageal cancer? World J Surg 2011;35:1311-20. [PMID: 21452070 DOI: 10.1007/s00268-011-1069-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
44 Azagra JS, Goergen M, Lens V, Ibáñez-aguirre JF, Schiltz M, Siciliano I. Present state of the Mini-Invasive Surgery (MIS) in esophageal and gastric cancer. Clin Transl Oncol 2006;8:173-7. [DOI: 10.1007/s12094-006-0007-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
45 Zhang W, Chen H, Zhang G, Jin G. A nomogram for predicting lymph node metastasis in superficial esophageal squamous cell carcinoma. J Biomed Res 2021;35:361-70. [PMID: 34628403 DOI: 10.7555/JBR.35.20210034] [Reference Citation Analysis]
46 Marjanovic G, Schricker M, Walch A, zur Hausen A, Hopt UT, Imdahl A, Makowiec F. Detection of lymph node involvement by cytokeratin immunohistochemistry is an independent prognostic factor after curative resection of esophageal cancer. J Gastrointest Surg. 2011;15:29-37. [PMID: 20976569 DOI: 10.1007/s11605-010-1359-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
47 Nobel TB, Barbetta A, Hsu M, Tan KS, Sihag S, Bains MS, Jones DR, Molena D. Ongoing Challenges with Clinical Assessment of Nodal Status in T1 Esophageal Adenocarcinoma. J Am Coll Surg 2019;229:366-73. [PMID: 31108196 DOI: 10.1016/j.jamcollsurg.2019.04.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
48 Sun L, Zhao F, Zeng Y, Yi C. Risks and Benefits of Multimodal Esophageal Cancer Treatments: A Meta-Analysis. Med Sci Monit 2017;23:889-910. [PMID: 28214903 DOI: 10.12659/msm.903328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
49 Theisen J, Feith M, Stein HJ, Siewert JR. Management of early esophageal cancer. Adv Surg 2007;41:229-39. [PMID: 17972568 DOI: 10.1016/j.yasu.2007.05.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
50 Ba-Ssalamah A, Matzek W, Baroud S, Bastati N, Zacherl J, Schoppmann SF, Hejna M, Wrba F, Weber M, Herold CJ. Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results. Eur Radiol. 2011;21:2326-2335. [PMID: 21710266 DOI: 10.1007/s00330-011-2187-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
51 Mauad EC, do Rosario Dias de Oliveira Latorre M, Silva TB, Daher RM, de Lima Vazquez V, Oliveira ATT, Filho AL. Analysis of Survival Rates of Patients Diagnosed With Incipient Esophagic Cancer. World J Oncol 2010;1:35-41. [PMID: 29147177 DOI: 10.4021/wjon2010.02.193w] [Reference Citation Analysis]
52 Matsuda S, Takeuchi H, Kawakubo H, Kitagawa Y. Three-field lymph node dissection in esophageal cancer surgery. J Thorac Dis 2017;9:S731-40. [PMID: 28815069 DOI: 10.21037/jtd.2017.03.171] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
53 Yamada M, Oda I, Tanaka H, Abe S, Nonaka S, Suzuki H, Yoshinaga S, Kuchiba A, Koyanagi K, Igaki H, Taniguchi H, Sekine S, Saito Y, Tachimori Y. Tumor location is a risk factor for lymph node metastasis in superficial Barrett's adenocarcinoma. Endosc Int Open 2017;5:E868-74. [PMID: 28924592 DOI: 10.1055/s-0043-115388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
54 Mino-kenudson M, Hull MJ, Brown I, Muzikansky A, Srivastava A, Glickman J, Park D, Zuckerberg L, Misdraji J, Odze RD, Lauwers GY. EMR for Barrett's esophagus–related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy. Gastrointestinal Endoscopy 2007;66:660-6. [DOI: 10.1016/j.gie.2007.02.063] [Cited by in Crossref: 92] [Cited by in F6Publishing: 66] [Article Influence: 6.1] [Reference Citation Analysis]
55 Haidry RJ, Butt MA, Dunn JM, Gupta A, Lipman G, Smart HL, Bhandari P, Smith L, Willert R, Fullarton G, Di Pietro M, Gordon C, Penman I, Barr H, Patel P, Kapoor N, Hoare J, Narayanasamy R, Ang Y, Veitch A, Ragunath K, Novelli M, Lovat LB; UK RFA Registry. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry. Gut 2015;64:1192-9. [PMID: 25539672 DOI: 10.1136/gutjnl-2014-308501] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
56 Lee JY, Kim YH, Park YJ, Park SB, Chung HW, Zo JI, Shim YM, Lee KS, Choi JY. Improved detection of metastatic lymph nodes in oesophageal squamous cell carcinoma by combined interpretation of fluorine-18-fluorodeoxyglucose positron-emission tomography/computed tomography. Cancer Imaging 2019;19:40. [PMID: 31227017 DOI: 10.1186/s40644-019-0225-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
57 Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol 2014;27:1578-89. [PMID: 24762549 DOI: 10.1038/modpathol.2014.66] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
58 Spechler SJ, Fitzgerald RC, Prasad GA, Wang KK. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterology. 2010;138:854-869. [PMID: 20080098 DOI: 10.1053/j.gastro.2010.01.002] [Cited by in Crossref: 142] [Cited by in F6Publishing: 112] [Article Influence: 11.8] [Reference Citation Analysis]
59 Gotink AW, van de Ven SEM, Ten Kate FJC, Nieboer D, Suzuki L, Weusten BLAM, Brosens LAA, van Hillegersberg R, Alvarez Herrero L, Seldenrijk CA, Alkhalaf A, Moll FCP, Schoon EJ, van Lijnschoten I, Tang TJ, van der Valk H, Nagengast WB, Kats-Ugurlu G, Plukker JTM, Houben MHMG, van der Laan JS, Pouw RE, Bergman JJGHM, Meijer SL, van Berge Henegouwen MI, Wijnhoven BPL, de Jonge PJF, Doukas M, Bruno MJ, Biermann K, Koch AD. Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. Endoscopy 2021. [PMID: 33626582 DOI: 10.1055/a-1399-4989] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Gervasoni JE Jr, Sbayi S, Cady B. Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data. Ann Surg Oncol 2007;14:2443-62. [PMID: 17597349 DOI: 10.1245/s10434-007-9360-5] [Cited by in Crossref: 48] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
61 Takeuchi A, Hatta W, Koike T, Saito M, Jin X, Asanuma K, Uno K, Asano N, Imatani A, Fujishima F, Masamune A. A Primary Barrett's Adenocarcinoma with a Squamous Cell Carcinoma Component. Intern Med 2019;58:2467-72. [PMID: 31118396 DOI: 10.2169/internalmedicine.2722-19] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Kruszewski WJ. Endoscopic methods in the treatment of early-stage esophageal cancer. Wideochir Inne Tech Maloinwazyjne 2014;9:125-30. [PMID: 25097676 DOI: 10.5114/wiitm.2014.41620] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
63 Shah R, Willingham FF. Endoscopic Resection for Early-Stage Esophageal Cancer, Are We There for Squamous As Well? Clin Transl Gastroenterol 2017;8:e130. [PMID: 29240732 DOI: 10.1038/ctg.2017.56] [Reference Citation Analysis]
64 Konda VJ, Dalal K. Optimal management of Barrett's esophagus: pharmacologic, endoscopic, and surgical interventions. Ther Clin Risk Manag 2011;7:447-58. [PMID: 22162921 DOI: 10.2147/TCRM.S23425] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
65 Wani S, Abrams J, Edmundowicz SA, Gaddam S, Hovis CE, Green D, Gupta N, Higbee A, Bansal A, Rastogi A, Early D, Lightdale CJ, Sharma P. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study. Dig Dis Sci 2013;58:1703-9. [PMID: 23633158 DOI: 10.1007/s10620-013-2689-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
66 Kitagawa Y, Kitajima M. Gastroesophageal carcinoma: individualized surgical therapy. Surg Oncol Clin N Am 2006;15:793-802. [PMID: 17030274 DOI: 10.1016/j.soc.2006.07.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
67 Zhang H, Huang Z, Song Y, Yang Z, Shi Q, Wang K, Zhang Z, Liu Z, Cui X, Li F. The TP53-Related Signature Predicts Immune Cell Infiltration, Therapeutic Response, and Prognosis in Patients With Esophageal Carcinoma. Front Genet 2021;12:607238. [PMID: 34234806 DOI: 10.3389/fgene.2021.607238] [Reference Citation Analysis]
68 Nassri A, Zhu H, Muftah M, Ramzan Z. Epidemiology and Survival of Esophageal Cancer Patients in an American Cohort. Cureus 2018;10:e2507. [PMID: 29930885 DOI: 10.7759/cureus.2507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
69 Leclercq P, Bisschops R. Optimizing Outcomes with Radiofrequency Ablation of Barrett's Esophagus: Candidates, Efficacy and Durability. Gastrointest Endosc Clin N Am 2021;31:131-54. [PMID: 33213792 DOI: 10.1016/j.giec.2020.09.004] [Reference Citation Analysis]
70 Ishihara R, Oyama T, Abe S, Takahashi H, Ono H, Fujisaki J, Kaise M, Goda K, Kawada K, Koike T, Takeuchi M, Matsuda R, Hirasawa D, Yamada M, Kodaira J, Tanaka M, Omae M, Matsui A, Kanesaka T, Takahashi A, Hirooka S, Saito M, Tsuji Y, Maeda Y, Yamashita H, Oda I, Tomita Y, Matsunaga T, Terai S, Ozawa S, Kawano T, Seto Y. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52:800-808. [PMID: 27757547 DOI: 10.1007/s00535-016-1275-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
71 Tachibana M, Hirahara N, Kinugasa S, Yoshimura H. Clinicopathologic Features of Superficial Esophageal Cancer: Results of Consecutive 100 Patients. Ann Surg Oncol 2008;15:104-16. [DOI: 10.1245/s10434-007-9604-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
72 Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012;143:336-346. [PMID: 22537613 DOI: 10.1053/j.gastro.2012.04.032] [Cited by in Crossref: 263] [Cited by in F6Publishing: 225] [Article Influence: 26.3] [Reference Citation Analysis]
73 Tong D, Law S. Extended Lymphadenectomy in Esophageal Cancer is Crucial. World J Surg 2013;37:1751-6. [DOI: 10.1007/s00268-013-2068-8] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
74 Zhang Y, Ren H, Wang L, Ning Z, Zhuang Y, Gan J, Chen S, Zhou D, Zhu H, Tan D. Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma. Int J Mol Sci. 2014;15:9718-9734. [PMID: 24886814 DOI: 10.3390/ijms15069718] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
75 Rajendra S, Sharma P. Barrett's Esophagus. Curr Treat Options Gastroenterol 2014;12:169-82. [PMID: 24634008 DOI: 10.1007/s11938-014-0012-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
76 Gilbert EW, Luna RA, Harrison VL, Hunter JG. Barrett’s esophagus: a review of the literature. J Gastrointest Surg. 2011;15:708-718. [PMID: 21461873 DOI: 10.1007/s11605-011-1485-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
77 Siddique MZ, Mehmood S, Ismail M, Yasmeen A, Asad-Ur-Rehman, Abu Bakar M, Khattak S, Syed AA, Yusuf MA. Pre-operative percutaneous endoscopic gastrostomy tube placement does not increase post-operative complications or mortality in oesophageal cancer. J Gastrointest Oncol 2019;10:492-8. [PMID: 31183199 DOI: 10.21037/jgo.2019.03.08] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Hagens ERC, van Berge Henegouwen MI, Cuesta MA, Gisbertz SS. The extent of lymphadenectomy in esophageal resection for cancer should be standardized. J Thorac Dis 2017;9:S713-23. [PMID: 28815067 DOI: 10.21037/jtd.2017.07.42] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
79 Oh DS, Hagen JA, Chandrasoma PT, Dunst CM, Demeester SR, Alavi M, Bremner CG, Lipham J, Rizzetto C, Cote R, Demeester TR. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg 2006;203:152-61. [PMID: 16864027 DOI: 10.1016/j.jamcollsurg.2006.05.006] [Cited by in Crossref: 80] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
80 Yang Z, Hui Y, Peng H, Zhang H, Li M, Song L, Li F, Cui X. Identification of a PLCE1‑regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinoma. Oncol Rep 2021;45:857-68. [PMID: 33650665 DOI: 10.3892/or.2021.7921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Wolf MC, Stahl M, Krause BJ, Bonavina L, Bruns C, Belka C, Zehentmayr F. Curative treatment of oesophageal carcinoma: current options and future developments. Radiat Oncol. 2011;6:55. [PMID: 21615894 DOI: 10.1186/1748-717x-6-55] [Cited by in Crossref: 29] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
82 Siewert J. Ösophaguskarzinom. Chirurg 2007;78:475-86. [DOI: 10.1007/s00104-007-1327-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
83 Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg. 2007;11:1384-193; discussion 1384-193;. [PMID: 17764019 DOI: 10.1007/s11605-007-0264-2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 6.6] [Reference Citation Analysis]
84 Yang D, Faraz F, Wang J, Radacsi N. Combination of 3D Printing and Electrospinning Techniques for Biofabrication. Adv Materials Technologies. [DOI: 10.1002/admt.202101309] [Reference Citation Analysis]
85 Tian Y, Wang C, Lu M. BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus. Surg Today 2019;49:158-69. [PMID: 30182305 DOI: 10.1007/s00595-018-1711-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
86 Upchurch E, Griffiths S, Lloyd GR, Isabelle M, Kendall C, Barr H. Developments in optical imaging for gastrointestinal surgery. Future Oncol 2017;13:2363-82. [PMID: 29121775 DOI: 10.2217/fon-2017-0181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
87 Strauss AC, Agoston AT, Dulai PS, Srivastava A, Rothstein RI. Radiofrequency ablation for Barrett's-associated intramucosal carcinoma: a multi-center follow-up study. Surg Endosc. 2014;28:3366-3372. [PMID: 24950726 DOI: 10.1007/s00464-014-3629-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
88 Ballard DD, Choksi N, Lin J, Choi EY, Elmunzer BJ, Appelman H, Rex DK, Fatima H, Kessler W, DeWitt JM. Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection. World J Gastrointest Endosc 2016; 8(20): 763-769 [PMID: 28042390 DOI: 10.4253/wjge.v8.i20.763] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
89 Aoki Y, Toh Y, Taomoto J, Sakaguchi Y, Okamura T. Long-term survival following radical surgery after chemotherapy for esophagogastric adenocarcinoma with extensive lymph node metastases: report of a case. Surg Today 2011;41:1255-9. [PMID: 21874426 DOI: 10.1007/s00595-010-4463-1] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
90 Omae M, Fujisaki J, Shimizu T, Horiuchi Y, Ishiyama A, Yoshio T, Hirasawa T, Yamamoto Y, Tsuchida T, Igarashi M, Seto Y. Correlation of the location of superficial Barrett's esophageal adenocarcinoma (s-BEA) with the direction of gastroesophageal reflux. Endosc Int Open 2016;4:E515-20. [PMID: 27227107 DOI: 10.1055/s-0042-101757] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
91 Xu Y, Yu X, Chen Q, Mao W. Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma? World J Surg Oncol 2012;10:173. [PMID: 22920951 DOI: 10.1186/1477-7819-10-173] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
92 Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology. 2011;140:e18-52; quiz e13. [PMID: 21376939 DOI: 10.1053/j.gastro.2011.01.031] [Cited by in Crossref: 766] [Cited by in F6Publishing: 517] [Article Influence: 69.6] [Reference Citation Analysis]
93 Chadwick G, Riley S, Hardwick RH, Crosby T, Hoare J, Hanna G, Greenaway K, Varagunam M, Cromwell DA, Groene O. Population-based cohort study of the management and survival of patients with early-stage oesophageal adenocarcinoma in England. Br J Surg 2016;103:544-52. [PMID: 26865114 DOI: 10.1002/bjs.10116] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
94 Cho JW, Choi SC, Jang JY, Shin SK, Choi KD, Lee JH, Kim SG, Sung JK, Jeon SW, Choi IJ, Kim GH, Jee SR, Lee WS, Jung HY; Korean ESD Study Group. Lymph Node Metastases in Esophageal Carcinoma: An Endoscopist's View. Clin Endosc. 2014;47:523-529. [PMID: 25505718 DOI: 10.5946/ce.2014.47.6.523] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
95 Old OJ, Almond LM, Barr H. Barrett's oesophagus: how should we manage it? Frontline Gastroenterol 2015;6:108-16. [PMID: 28839797 DOI: 10.1136/flgastro-2014-100552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 O'Farrell NJ, Reynolds JV, Ravi N, Larkin JO, Malik V, Wilson GF, Muldoon C, O'Toole D. Evolving changes in the management of early oesophageal adenocarcinoma in a tertiary centre. Ir J Med Sci 2013;182:363-9. [PMID: 23242575 DOI: 10.1007/s11845-012-0890-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
97 Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Hölscher AH. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg. 2011;254:67-72. [PMID: 21532466 DOI: 10.1097/sla.0b013e31821d4bf6] [Cited by in Crossref: 189] [Cited by in F6Publishing: 69] [Article Influence: 17.2] [Reference Citation Analysis]
98 Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol. 2012;107:850-62; quiz 863. [PMID: 22488081 DOI: 10.1038/ajg.2012.78] [Cited by in Crossref: 150] [Cited by in F6Publishing: 122] [Article Influence: 15.0] [Reference Citation Analysis]
99 Kandiah K, Chedgy FJ, Subramaniam S, Thayalasekaran S, Kurup A, Bhandari P. Early squamous neoplasia of the esophagus: The endoscopic approach to diagnosis and management. Saudi J Gastroenterol 2017;23:75-81. [PMID: 28361837 DOI: 10.4103/1319-3767.203366] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
100 Konda VJ, Waxman I. Low risk of prevalent submucosal invasive cancer among patients undergoing esophagectomy for treatment of Barrett's esophagus with high grade dysplasia. J Gastrointest Oncol 2011;2:1-4. [PMID: 22811818 DOI: 10.3978/j.issn.2078-6891.2011.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
101 Horváth OP. [Surgical treatment for early Barrett cancer]. Magy Seb 2009;62:51-8. [PMID: 19386564 DOI: 10.1556/MaSeb.62.2009.2.1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
102 Wong CL, Law S. Extent of lymphadenectomy for Barrett's cancer. Transl Gastroenterol Hepatol 2019;4:36. [PMID: 31231703 DOI: 10.21037/tgh.2019.05.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
103 Namasivayam V, Wang KK, Prasad GA. Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions. Clin Gastroenterol Hepatol. 2010;8:743-54; quiz e96. [PMID: 20541628 DOI: 10.1016/j.cgh.2010.05.030] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
104 Veeramootoo D, Shore AC, Wajed SA. Randomized controlled trial of laparoscopic gastric ischemic conditioning prior to minimally invasive esophagectomy, the LOGIC trial. Surg Endosc. 2012;26:1822-1829. [PMID: 22302533 DOI: 10.1007/s00464-011-2123-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
105 Davison JM, Landau MS, Luketich JD, McGrath KM, Foxwell TJ, Landsittel DP, Gibson MK, Nason KS. A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes. Clin Gastroenterol Hepatol 2016;14:369-377.e3. [PMID: 26515637 DOI: 10.1016/j.cgh.2015.10.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
106 May A, Ell C. Diagnosis and treatment of early esophageal cancer: . Current Opinion in Gastroenterology 2006;22:433-6. [DOI: 10.1097/01.mog.0000231821.48890.e6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
107 Schlosser T, Hoffmeister A, Feisthammel J, Niebisch S, Thieme R, Gockel I. [Treatment recommendations for early esophageal cancer : Endoscopic and surgical options]. Chirurg 2021;92:1077-84. [PMID: 34622303 DOI: 10.1007/s00104-021-01513-7] [Reference Citation Analysis]
108 Hachey KJ, Gilmore DM, Armstrong KW, Harris SE, Hornick JL, Colson YL, Wee JO. Safety and feasibility of near-infrared image-guided lymphatic mapping of regional lymph nodes in esophageal cancer. J Thorac Cardiovasc Surg 2016;152:546-54. [PMID: 27179838 DOI: 10.1016/j.jtcvs.2016.04.025] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
109 Cense HA, van Eijck CH, Tilanus HW. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol. 2006;20:893-906. [PMID: 16997168 DOI: 10.1016/j.bpg.2006.03.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
110 Greenwald BD, Dumot JA, Abrams JA, Lightdale CJ, David DS, Nishioka NS, Yachimski P, Johnston MH, Shaheen NJ, Zfass AM, Smith JO, Gill KR, Burdick JS, Mallat D, Wolfsen HC. Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy. Gastrointest Endosc. 2010;71:686-693. [PMID: 20363410 DOI: 10.1016/j.gie.2010.01.042] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 7.6] [Reference Citation Analysis]
111 Yang J, Liu Y, Li B, Jiang P, Wang C. Prognostic significance of tumor length in patients with esophageal cancer undergoing radical resection: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2019;98:e15029. [PMID: 30946339 DOI: 10.1097/MD.0000000000015029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
112 Stein HJ, Hutter J, Feith M, von Rahden BH. Limited surgical resection and jejunal interposition for early adenocarcinoma of the distal esophagus. Semin Thorac Cardiovasc Surg 2007;19:72-8. [PMID: 17403461 DOI: 10.1053/j.semtcvs.2006.11.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
113 Li Z, Liu C, Liu Y, Yao S, Xu B, Dong G. Comparisons between minimally invasive and open esophagectomy for esophageal cancer with cervical anastomosis: a retrospective study. J Cardiothorac Surg 2020;15:128. [PMID: 32513211 DOI: 10.1186/s13019-020-01182-3] [Reference Citation Analysis]
114 Wolfsen HC, Hemminger LL. Salvage photodynamic therapy for persistent esophageal cancer after chemoradiation therapy. Photodiagnosis and Photodynamic Therapy 2006;3:11-4. [DOI: 10.1016/s1572-1000(06)00002-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Gockel I, Hoffmeister A. Endoscopic or Surgical Resection for Gastro-Esophageal Cancer. Dtsch Arztebl Int 2018;115:513-9. [PMID: 30149830 DOI: 10.3238/arztebl.2018.0513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
116 Cummings Iii KC, Kou TD, Chak A, Schluchter MD, Margevicius S, Cooper GS, Meropol NJ, Perry Y, Linden PA, Cummings LC. Surgical approach and the impact of epidural analgesia on survival after esophagectomy for cancer: A population-based retrospective cohort study. PLoS One 2019;14:e0211125. [PMID: 30668599 DOI: 10.1371/journal.pone.0211125] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
117 Qiao YY, Lin KX, Zhang Z, Zhang DJ, Shi CH, Xiong M, Qu XH, Zhao XH. Monitoring disease progression and treatment efficacy with circulating tumor cells in esophageal squamous cell carcinoma: A case report. World J Gastroenterol 2015; 21(25): 7921-7928 [PMID: 26167094 DOI: 10.3748/wjg.v21.i25.7921] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
118 Kidane B, Ali A, Sulman J, Wong R, Knox JJ, Darling GE. Health-related quality of life measure distinguishes between low and high clinical T stages in esophageal cancer. Ann Transl Med 2018;6:270. [PMID: 30094256 DOI: 10.21037/atm.2018.06.03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
119 Haidry RJ, Butt MA, Dunn J, Banks M, Gupta A, Smart H, Bhandari P, Smith LA, Willert R, Fullarton G, John M, Pietro MD, Penman I, Novelli M, Lovat LB. Radiofrequency ablation for early oesophageal squamous neoplasia: Outcomes form United Kingdom registry. World J Gastroenterol 2013; 19(36): 6011-6019 [PMID: 24106401 DOI: 10.3748/wjg.v19.i36.6011] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
120 Kinoshita T, Gotohda N, Kato Y, Takahashi S, Konishi M, Okazumi S, Katoh R, Kinoshita T. Laparoscopic transhiatal resection for Siewert type II adenocarcinoma of the esophagogastric junction: operative technique and initial results. Surg Laparosc Endosc Percutan Tech. 2012;22:e199-e203. [PMID: 22874699 DOI: 10.1097/sle.0b013e31825a72e2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
121 Ishihara R, Yamamoto S, Hanaoka N, Takeuchi Y, Higashino K, Uedo N, Iishi H. Endoscopic submucosal dissection for superficial Barrett's esophageal cancer in the Japanese state and perspective. Ann Transl Med 2014;2:24. [PMID: 25333000 DOI: 10.3978/j.issn.2305-5839.2014.02.03] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
122 von Rahden BHA, Stein HJ. Barrett's esophagus with high-grade intraepithelial neoplasia: observation, ablation or resection? Eur Surg 2007;39:249-54. [DOI: 10.1007/s10353-007-0337-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
123 Ji X, Cai J, Chen Y, Chen LQ. Lymphatic spreading and lymphadenectomy for esophageal carcinoma. World J Gastrointest Surg 2016; 8(1): 90-94 [PMID: 26843917 DOI: 10.4240/wjgs.v8.i1.90] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
124 Old OJ, Isabelle M, Barr H. Staging Early Esophageal Cancer. Adv Exp Med Biol 2016;908:161-81. [PMID: 27573772 DOI: 10.1007/978-3-319-41388-4_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
125 Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Mcginn TG, Wisnivesky JP. Racial Disparities in Esophageal Cancer Treatment and Outcomes. Ann Surg Oncol 2008;15:881-8. [DOI: 10.1245/s10434-007-9664-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
126 Fernández-Sordo JO, Konda VJ, Chennat J, Madrigal-Hoyos E, Posner MC, Ferguson MK, Waxman I. Is Endoscopic Ultrasound (EUS) necessary in the pre-therapeutic assessment of Barrett's esophagus with early neoplasia? J Gastrointest Oncol 2012;3:314-21. [PMID: 23205307 DOI: 10.3978/j.issn.2078-6891.2012.038] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
127 Manner H, Pech O. Measurement of the tumor invasion depth into the submucosa in early adenocarcinoma of the esophagus (pT1b): Can microns be the new standard for the endoscopist? United European Gastroenterol J 2015;3:501-4. [PMID: 26668742 DOI: 10.1177/2050640615617724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
128 Feith M, Stein HJ, Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am. 2006;15:751-764. [PMID: 17030271 DOI: 10.1016/j.soc.2006.07.015] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 5.2] [Reference Citation Analysis]
129 Sendler A. [Tumors of the upper gastro-intestinal tract]. Chirurg 2010;81:103-6; 108-10. [PMID: 20076935 DOI: 10.1007/s00104-009-1813-x] [Reference Citation Analysis]
130 Benech N, O'Brien JM, Barret M, Jacques J, Rahmi G, Perrod G, Hervieu V, Jaouen A, Charissoux A, Guillaud O, Legros R, Walter T, Saurin JC, Rivory J, Prat F, Lépilliez V, Ponchon T, Pioche M. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases. United European Gastroenterol J 2021;9:362-9. [PMID: 32903167 DOI: 10.1177/2050640620958903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Siewert JR, Feith M, Stein HJ. Ösophagektomie als chirurgisches Therapieprinzip beim Plattenepithelkarzinom des Ösophagus. Chirurg 2005;76:1033-43. [DOI: 10.1007/s00104-005-1096-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
132 Pyo JH, Lee H, Min BH, Lee JH, Choi MG, Lee JH, Sohn TS, Bae JM, Kim KM, Ahn HS, Jung SH, Kim S, Kim JJ. A Risk Prediction Model Based on Lymph-Node Metastasis in Poorly Differentiated-Type Intramucosal Gastric Cancer. PLoS One 2016;11:e0156207. [PMID: 27228258 DOI: 10.1371/journal.pone.0156207] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
133 Akiyama J, Roorda A, Triadafilopoulos G. Managing Barrett's esophagus with radiofrequency ablation. Gastroenterol Rep (Oxf) 2013;1:95-104. [PMID: 24759814 DOI: 10.1093/gastro/got009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
134 van der Wel MJ, Jansen M, Vieth M, Meijer SL. What Makes an Expert Barrett’s Histopathologist? In: Jansen M, Wright NA, editors. Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract. Cham: Springer International Publishing; 2016. pp. 137-59. [DOI: 10.1007/978-3-319-41388-4_8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
135 Schölvinck D, Künzli H, Meijer S, Seldenrijk K, van Berge Henegouwen M, Bergman J, Weusten B. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease. Surg Endosc. 2016;30:4102-4113. [PMID: 27357927 DOI: 10.1007/s00464-016-5071-y] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
136 Nafteux P, Depypere L, Van Veer H, Coosemans W, Lerut T. Principles of esophageal cancer surgery, including surgical approaches and optimal node dissection (2- vs. 3-field). Ann Cardiothorac Surg 2017;6:152-8. [PMID: 28447004 DOI: 10.21037/acs.2017.03.04] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
137 Na KJ, Kang CH. Current Issues in Minimally Invasive Esophagectomy. Korean J Thorac Cardiovasc Surg 2020;53:152-9. [PMID: 32793445 DOI: 10.5090/kjtcs.2020.53.4.152] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
138 DeMeester SR. Evaluation and treatment of superficial esophageal cancer. J Gastrointest Surg. 2010;14 Suppl 1:S94-S100. [PMID: 19760303 DOI: 10.1007/s11605-009-1025-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
139 Siewert JR, Ott K. Are squamous and adenocarcinomas of the esophagus the same disease? Semin Radiat Oncol 2007;17:38-44. [PMID: 17185196 DOI: 10.1016/j.semradonc.2006.09.007] [Cited by in Crossref: 172] [Cited by in F6Publishing: 169] [Article Influence: 11.5] [Reference Citation Analysis]
140 Chedgy FJ, Kandiah K, Thayalasekaran S, Subramaniam S, Bhandari P. Advances in the endoscopic diagnosis and treatment of Barrett's neoplasia. F1000Res 2016;5:F1000 Faculty Rev-113. [PMID: 26918175 DOI: 10.12688/f1000research.6996.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
141 Ishihara R, Goda K, Oyama T. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus. J Gastroenterol 2019;54:1-9. [PMID: 29961130 DOI: 10.1007/s00535-018-1491-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
142 Kakeji Y, Yamamoto M, Ito S, Sugiyama M, Egashira A, Saeki H, Morita M, Sakaguchi Y, Toh Y, Maehara Y. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today. 2012;42:351-358. [PMID: 22245924 DOI: 10.1007/s00595-011-0114-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
143 Filip B, Scarpa M, Cavallin F, Alfieri R, Cagol M, Castoro C. Minimally invasive surgery for esophageal cancer: a review on sentinel node concept. Surg Endosc. 2014;28:1238-1249. [PMID: 24281431 DOI: 10.1007/s00464-013-3314-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
144 Siddiqui FA, Atkins KM, Diggs BS, Thomas CR Jr, Hunter JG, Dolan JP. Overall survival analysis of neoadjuvant chemoradiotherapy and esophagectomy for esophageal cancer. J Gastrointest Oncol 2014;5:86-91. [PMID: 24772335 DOI: 10.3978/j.issn.2078-6891.2014.014] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
145 Miyawaki Y, Sato H, Fujiwara N, Oya S, Sugita H, Hirano Y, Yamane T, Sakuramoto S, Okamoto K, Yamaguchi S, Koyama I. Association of the primary tumor's SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study. Int J Clin Oncol 2020;25:561-9. [PMID: 31867680 DOI: 10.1007/s10147-019-01606-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
146 Brücher BL, Kitajima M, Siewert JR. Undervalued criteria in the evaluation of multimodal trials for upper GI cancers. Cancer Invest 2014;32:497-506. [PMID: 25250506 DOI: 10.3109/07357907.2014.958497] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
147 Sgourakis G, Gockel I, Lyros O, Lanitis S, Dedemadi G, Polotzek U, Karaliotas C, Lang H. The Use of Neural Networks in Identifying Risk Factors for Lymph Node Metastasis and Recommending Management of T1b Esophageal Cancer. The American Surgeon 2012;78:195-206. [DOI: 10.1177/000313481207800238] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
148 Wolf M, Zehentmayr F, Niyazi M, Ganswindt U, Haimerl W, Schmidt M, Hölzel D, Belka C. Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer. Strahlenther Onkol. 2010;186:374-381. [PMID: 20582393 DOI: 10.1007/s00066-010-2137-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
149 Park SY, Kim DJ, Son T, Lee YC, Lee CY, Lee JG, Chung KY. Extent of Mediastinal Lymphadenectomy and Survival in Superficial Esophageal Squamous Cell Carcinoma. J Gastrointest Surg 2017;21:1584-90. [PMID: 28646334 DOI: 10.1007/s11605-017-3471-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
150 Siewert JR, Stein HJ, Feith M. Adenocarcinoma of the esophago-gastric junction. Scand J Surg. 2006;95:260-269. [PMID: 17249275 DOI: 10.1177/145749690609500409] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 4.9] [Reference Citation Analysis]
151 Lekakos L, Karidis NP, Dimitroulis D, Tsigris C, Kouraklis G, Nikiteas N. Barrett's esophagus with high-grade dysplasia: Focus on current treatment options. World J Gastroenterol 2011; 17(37): 4174-4183 [PMID: 22072848 DOI: 10.3748/wjg.v17.i37.4174] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
152 Pennathur A, Farkas A, Krasinskas AM, Ferson PF, Gooding WE, Gibson MK, Schuchert MJ, Landreneau RJ, Luketich JD. Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. Ann Thorac Surg. 2009;87:1048-54; discussion 1054-5. [PMID: 19324126 DOI: 10.1016/j.athoracsur.2008.12.060] [Cited by in Crossref: 182] [Cited by in F6Publishing: 159] [Article Influence: 14.0] [Reference Citation Analysis]
153 Sakai A, Nakashima Y, Miyashita Y, Ao T, Kimura Y, Shinto E, Oki E, Shimokawa M, Ueno H, Oda Y, Mori M. Histological categorisation of the desmoplastic reaction is a predictor of patient prognosis in oesophageal squamous cell carcinoma. Histopathology 2021;79:219-26. [PMID: 33595141 DOI: 10.1111/his.14357] [Reference Citation Analysis]
154 Sjöqvist S, Jungebluth P, Lim ML, Haag JC, Gustafsson Y, Lemon G, Baiguera S, Burguillos MA, Del Gaudio C, Rodríguez AB, Sotnichenko A, Kublickiene K, Ullman H, Kielstein H, Damberg P, Bianco A, Heuchel R, Zhao Y, Ribatti D, Ibarra C, Joseph B, Taylor DA, Macchiarini P. Experimental orthotopic transplantation of a tissue-engineered oesophagus in rats. Nat Commun 2014;5:3562. [PMID: 24736316 DOI: 10.1038/ncomms4562] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
155 Bollschweiler E, Hölscher AH. Prognosis of early esophageal cancer: differences between squamous cell carcinoma and adenocarcinoma. Ann Surg 2007;245:334. [PMID: 17245190 DOI: 10.1097/01.sla.0000253072.33351.a4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
156 Ekeke CN, Chan EG, Fabian T, Villa-Sanchez M, Luketich JD. Recommendations for Surveillance and Management of Recurrent Esophageal Cancer Following Endoscopic Therapies. Surg Clin North Am 2021;101:415-26. [PMID: 34048762 DOI: 10.1016/j.suc.2021.03.004] [Reference Citation Analysis]
157 Schmidt HM, Mohiuddin K, Bodnar AM, El Lakis M, Kaplan S, Irani S, Gan I, Ross A, Low DE. Multidisciplinary treatment of T1a adenocarcinoma in Barrett's esophagus: contemporary comparison of endoscopic and surgical treatment in physiologically fit patients. Surg Endosc 2016;30:3391-401. [PMID: 26541725 DOI: 10.1007/s00464-015-4621-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
158 Davison JM, Yee M, Krill-Burger JM, Lyons-Weiler MA, Kelly LA, Sciulli CM, Nason KS, Luketich JD, Michalopoulos GK, LaFramboise WA. The degree of segmental aneuploidy measured by total copy number abnormalities predicts survival and recurrence in superficial gastroesophageal adenocarcinoma. PLoS One 2014;9:e79079. [PMID: 24454681 DOI: 10.1371/journal.pone.0079079] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
159 Wang CP, Rogers MP, Bach G, Sujka J, Mhaskar R, DuCoin C. Safety comparison of minimally invasive abdomen-only esophagectomy versus minimally invasive Ivor Lewis esophagectomy: a retrospective cohort study. Surg Endosc 2021. [PMID: 33825009 DOI: 10.1007/s00464-021-08468-0] [Reference Citation Analysis]
160 Lal P, Thota PN. Cryotherapy in the management of premalignant and malignant conditions of the esophagus. World J Gastroenterol 2018; 24(43): 4862-4869 [PMID: 30487696 DOI: 10.3748/wjg.v24.i43.4862] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
161 Lee NR, Meng RY, Rah SY, Jin H, Ray N, Kim SH, Park BH, Kim SM. Reactive Oxygen Species-Mediated Autophagy by Ursolic Acid Inhibits Growth and Metastasis of Esophageal Cancer Cells. Int J Mol Sci 2020;21:E9409. [PMID: 33321911 DOI: 10.3390/ijms21249409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Cummings LC, Kou TD, Schluchter MD, Chak A, Cooper GS. Outcomes after endoscopic versus surgical therapy for early esophageal cancers in an older population. Gastrointest Endosc 2016;84:232-240.e1. [PMID: 26801375 DOI: 10.1016/j.gie.2016.01.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
163 McLaren PJ, Dolan JP. Surgical Treatment of High-Grade Dysplasia and Early Esophageal Cancer. World J Surg 2017;41:1712-8. [PMID: 28258451 DOI: 10.1007/s00268-017-3958-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]